* denotes 2023 Innovation Award Winner
Human Brain Disease ModelsAn avant-garde company making a novel, first in class, Neural Organoid Platform™ that mimics the human central nervous system. To study human brain disease mechanisms To create early diagnostic test To facilitate drug discovery, efficacy and safety testing
Z-pods®Zylö Therapeutics licensed an innovative topical drug delivery system in 2017. The system, based on silica-derived microparticles called Z-pods®, held the promise of enhancing the bioavailability of many topically applied active ingredients (AIs) for animals, plants, and humans. Zylö has advanced the technology and readied it for commercialization.